Ocular Therapeutix (OCUL) Return on Sales (2014 - 2026)

Ocular Therapeutix's Return on Sales history runs 13 years deep, the most recent figure standing at 0.08% for Q1 2026.

• In Q1 2026, Return on Sales fell 2.0% year-over-year to 0.08%; the TTM figure through Mar 2026 stood at 0.06% (down 2.0% YoY), while the FY2025 annual figure was 0.05%, down 2.0% from the prior year.
• Return on Sales was 0.08% for Q1 2026 at Ocular Therapeutix, down from 0.05% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q3 2023 to a low of 0.08% in Q1 2026.
• Historically, Return on Sales has averaged 0.03% across 5 years, with a median of 0.02% in 2024.
• The sharpest annual moves came in 2022 and 2025: Return on Sales gained 2 bps in 2022, then slipped 4 bps in 2025.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2022, then declined by 4 bps to 0.02% in 2023, then plunged by 87 bps to 0.03% in 2024, then tumbled by 72 bps to 0.05% in 2025, then sank by 70 bps to 0.08% in 2026.
• The last three Return on Sales figures came in at 0.08% (Q1 2026), 0.05% (Q4 2025), and 0.05% (Q3 2025), per Business Quant data.